LAVAL, Que. - About 100 people are being laid off by French pharmaceutical company Sanofi-Aventis in the Montreal area.
The layoffs at a research-and-development centre in suburban Laval are part of an ongoing restructuring by the global drug maker.
The company cited reasons including a desire to better integrate Genzyme, a biotech company acquired last year for more than US$20 billion.
The layoffs are more bad news for Montreal's pharmaceutical industry, one day after Johnson & Johnson announced the closure of its research centre and the layoff of 126 workers.
About 1,700 people work for Sanofi's Canadian division.